BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, December 16, 2025
Home » Authors » Katie Pfaff

Katie Pfaff

katie.pfaff@clarivate.com
Articles

ARTICLES

Zeiss acquires Veracity to speed answers to doctors during eye care procedures

Aug. 23, 2017
By Katie Pfaff
Carl Zeiss Meditech AG brings better efficiency and data to ophthalmologists during cataract surgery with its acquisition of Veracity Innovations LLC, a cloud-based platform company designed to increase results for clinicians. Clinical data and treatment information will be immediately available to physicians. Details of the acquisition were not disclosed.
Read More

FDA plasma panel to aid in standardizing Zika detection

Aug. 22, 2017
By Katie Pfaff

Endologix reports positive outcomes in ongoing study

Aug. 18, 2017
By Katie Pfaff

Venturemed closes $15M series B for Flex PAD portfolio

Aug. 17, 2017
By Katie Pfaff

Tandem launches pivotal trial for insulin pump, low blood sugar prediction technology

Aug. 16, 2017
By Katie Pfaff

MDxhealth study points to promising prostate cancer risk-screening tool

Aug. 15, 2017
By Katie Pfaff
An August study finds MDxhealth SA may have an effective tool in determining risk for prostate cancer with its ConfirmMDx screening. Aggressive prostate cancer (PCa) risk has historically been difficult to pinpoint, leading to false positives and unneeded treatment, as well as men who have cancer that biopsy did not detect.
Read More

Apollo endosurgery clarifies FDA letter on intragastric balloon safety

Aug. 14, 2017
By Katie Pfaff
Following an FDA letter issued Thursday Aug. 10 to health care providers about possible risks with liquid-filled intragastric balloons, Apollo Endosurgery Inc. held a call on Friday to address the letter. During the call, executives with Apollo, maker of the Orbera intragastric balloon system, discussed the FDA letter regarding unexpected deaths of five patients who had received the balloons, though their deaths were not determined to be the result of the devices, said the company.
Read More

Neosync raises $13M for Nest home-based depression device

Aug. 11, 2017
By Katie Pfaff

Bionik Arke exoskeleton gains voice control with Alexa, Echo

Aug. 10, 2017
By Katie Pfaff
Robotics firm Bionik Laboratories Corp. has updated its Arke exoskeleton with Amazon's Echo and Alexa. Patients can ask the system to stand or walk to activate Arke.
Read More

Optovue receives FDA nod for eye health indicator

Aug. 9, 2017
By Katie Pfaff
View All Articles by Katie Pfaff

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 15, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 16, 2025.
  • Novo Nordisk semaglutide pill

    CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

    BioWorld
    A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • Illustration of brain with electrical activity background

    ABS-1230 controls seizures in KCNT1-driven severe epilepsy

    BioWorld Science
    Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing